Psoriasis Stem Cell Therapy in Turkey

Advanced mesenchymal stem cell therapy and exosome therapy for psoriasis and autoimmune skin inflammation at our regenerative medicine clinic in Istanbul.

Plaque psoriasis · Autoimmune skin inflammation · Systemic immune modulation · Psoriatic arthritis considerations · Dermatology-linked review

International Patients
Accredited Facility
Dermatology Specialist Review
Cell Processing Lab

Understanding Psoriasis

Psoriasis is a chronic immune-mediated skin condition in which the immune system drives excessive inflammation and abnormally fast skin-cell turnover. Instead of the normal renewal cycle, the skin can begin producing cells too quickly, leading to thickened, scaly, inflamed plaques.

Many patients experience redness, scaling, itching, cracking, discomfort, and visible lesions that affect confidence and everyday quality of life. Some also develop nail changes, scalp involvement, or inflammatory joint symptoms consistent with psoriatic arthritis.

Conventional treatment may include topical steroids, vitamin D analogues, phototherapy, systemic medications, and biologics. Many patients begin exploring mesenchymal stem cell therapy and exosome therapy because they want an approach aimed at the immune environment itself rather than only visible skin lesions.

Psoriasis Is More Than a Skin Condition

Psoriasis is often misunderstood as a surface-level skin problem, but biologically it is linked to systemic immune dysregulation and chronic inflammation. That broader inflammatory context is one reason patients search for more comprehensive strategies beyond lesion-specific management.

Systemic Inflammation

Psoriasis is more than a skin disorder. It is associated with systemic inflammation that may affect broader health over time.

Psoriatic Arthritis Risk

A meaningful proportion of patients also develop joint symptoms, stiffness, or inflammatory arthritis linked to psoriasis.

Immune Dysregulation

The disease is driven by abnormal immune signaling involving T cells, cytokines, and inflammatory pathways rather than only a skin-surface issue.

Metabolic and Cardiovascular Burden

Chronic inflammatory states linked to psoriasis may overlap with broader systemic health risks in some patients.

Common Symptoms and Daily Burden

Patients seeking psoriasis stem cell therapy in Turkey often describe more than visible plaques alone:

Plaques, Scaling, and Redness

Psoriasis commonly causes raised, inflamed, scaly plaques that may appear on the scalp, elbows, knees, trunk, and other body areas.

Itching and Irritation

Many patients struggle with chronic itching, cracking, discomfort, bleeding, and skin sensitivity that interferes with sleep and daily comfort.

Flare Cycles and Unpredictability

Symptoms may improve and worsen over time, creating a frustrating pattern of relapses linked to stress, immune triggers, infection, or medication changes.

Psychological and Social Burden

Psoriasis can affect confidence, clothing choices, work, relationships, and overall quality of life far beyond the visible skin symptoms alone.

How Stem Cells May Help Psoriasis

Mesenchymal stem cells (MSCs) are being studied for psoriasis because they may interact with several immune and inflammatory pathways involved in autoimmune skin disease. The main interest is not local cosmetic camouflage. The real interest is whether broader immunomodulatory signaling may support a more stable inflammatory state.

  • Immunomodulation of Th17 cells and the IL-17 / IL-23 inflammatory axis linked to psoriasis activity
  • Suppression of pro-inflammatory cytokines such as TNF-alpha, IL-1 beta, and IL-6
  • Promotion of regulatory T-cell activity that may support immune tolerance
  • Anti-inflammatory paracrine signaling that may reduce systemic inflammatory burden
  • Support for healthier keratinocyte turnover and reduced inflammatory skin dysregulation
  • Possible modulation of dendritic cell activation involved in autoimmune cascade signaling

Immune Regulation

One of the main reasons patients explore stem cell therapy for psoriasis is the possibility of influencing the immune pathways driving the disease, especially the inflammatory axis involving T cells and cytokine signaling.

Systemic Inflammation Support

Because psoriasis can overlap with wider inflammatory burden, some patients are interested in approaches that do more than calm one patch of skin at a time. IV regenerative therapy is often explored with that broader immune-regulation goal in mind.

Skin and Joint Considerations

In patients with suspected or confirmed psoriatic arthritis, treatment planning may need to consider both dermatological disease and inflammatory joint symptoms together.

Living with Psoriasis?

Submit your dermatology records, PASI history if available, treatment history, and photographs of affected areas for a regenerative autoimmune evaluation in Istanbul.

Why Patients Explore Regenerative Psoriasis Therapy

Patients who inquire about treatment are often dealing with chronic recurrence, incomplete response to standard therapies, medication fatigue, visible skin burden, or joint symptoms that make the condition feel bigger than dermatology alone.

Immune Regulation Goals

Patients often explore regenerative therapy because psoriasis is fundamentally immune-mediated rather than just cosmetic or superficial.

Flare Reduction Support

Many are looking for better long-term inflammatory stability when conventional treatment gives incomplete control or repeated relapse.

Systemic Rather Than Local Approach

IV regenerative treatment is often explored because it aims at the broader immune environment instead of only individual lesions.

Joint and Skin Considerations Together

Patients with both skin disease and inflammatory joint symptoms may be especially interested in broader immunomodulatory strategies.

Who May Be Eligible for Psoriasis Stem Cell Therapy in Turkey

Eligibility depends on severity, treatment history, autoimmune burden, and whether the patient may still benefit from an investigational immunomodulatory approach:

  • Patients with moderate to severe psoriasis or recurrent flare patterns
  • Patients with widespread plaques, significant quality-of-life burden, or incomplete control with standard therapy
  • Patients with dermatology documentation, treatment history, and photographs or PASI records when available
  • Patients with suspected or confirmed psoriatic arthritis requiring broader autoimmune review
  • Patients who understand that treatment is investigational and should complement dermatologist-supervised care rather than replace it

Your Evaluation Process in Istanbul

  1. Record Review: Send dermatology notes, medication history, photographs, PASI information if available, and any rheumatology records if joint symptoms exist.
  2. Inflammatory Assessment: The case is reviewed based on severity, flare pattern, prior treatment response, and associated autoimmune burden.
  3. Protocol Planning: If appropriate, an immunomodulatory regenerative treatment plan is prepared around the patient's disease pattern and medical context.
  4. Treatment and Follow-Up: Patients receive treatment in Istanbul with continued guidance that works alongside ongoing dermatology management.

Why International Patients Choose Istanbul

Patients looking for psoriasis treatment in Turkey often want autoimmune-focused review, regenerative medicine access, easier international travel logistics, and a more favorable private-treatment cost structure.

Dermatology and Autoimmune Review

Psoriasis cases benefit from review of disease severity, treatment history, autoimmune burden, and any joint involvement before planning.

Advanced Regenerative Focus

Our protocols are designed for patients seeking stem cell and exosome-based immunomodulatory support for autoimmune inflammatory disease.

International Patient Access

Istanbul offers strong private medical infrastructure and practical travel access for international patients seeking regenerative medicine evaluation.

Cost Advantage

Turkey often offers a substantial cost advantage compared with many Western private regenerative treatment programs.

Frequently Asked Questions

No. Psoriasis is a chronic immune-mediated condition and stem cell therapy is not considered a cure. It is explored as an investigational immunomodulatory strategy that may help regulate the overactive immune response driving skin inflammation, plaque formation, and flare activity. Results vary and dermatological care remains important.

Our protocols focus on Wharton's Jelly–derived mesenchymal stem cells (WJ-MSCs), which are studied for immunomodulatory and anti-inflammatory properties that may be relevant to psoriasis and other autoimmune inflammatory conditions.

Mesenchymal stem cells are most commonly administered by intravenous (IV) infusion for systemic immune modulation. This approach targets the underlying immune dysregulation rather than treating individual skin plaques one by one.

Patients commonly hope for reduced plaque severity, less scaling, less itching, fewer flare-ups, improved skin appearance, and reduced inflammatory burden. Some also seek support for associated joint symptoms when psoriatic arthritis is a concern. Outcomes vary depending on disease severity, subtype, and individual immune biology.

Yes. Regenerative treatment should be viewed as complementary, not as a replacement for dermatology care. Patients may still need topical therapy, phototherapy, systemic medication review, or monitoring by their dermatologist.

Treatment in Istanbul is often significantly more affordable than comparable private regenerative protocols in the US or Western Europe. Final pricing depends on disease complexity, protocol design, exosome inclusion, and the level of medical review required.

Some patients with psoriasis also have joint symptoms consistent with psoriatic arthritis. In those cases, treatment planning may consider both the skin and the inflammatory joint component, but candidacy depends on the overall autoimmune picture and existing rheumatology care.

Please send dermatology notes, biopsy reports if available, PASI score history if available, photographs of affected areas, treatment history, medication list, and any rheumatology records if there is suspected or confirmed psoriatic arthritis.

Potential candidates may include patients with moderate to severe psoriasis, recurrent flares despite standard treatment, significant quality-of-life burden, widespread involvement, or psoriasis associated with systemic inflammatory issues. Final candidacy depends on medical history, current therapy, disease pattern, and specialist review.

No. Stem cell therapy for psoriasis is investigational and should not automatically replace biologic therapy, topical treatment, or dermatologist-supervised care. Medication decisions should be coordinated carefully with the treating specialist.

Medical Disclaimer

Stem cell therapy for psoriasis is investigational. Results vary and are not guaranteed. Treatment does not replace dermatological care, rheumatology care when relevant, or specialist-guided medication management.

Ready to Explore Your Treatment Options?

Schedule a free, no-obligation consultation with our regenerative medicine specialists. We treat patients from over 40 countries.

Or call directly: +90 534 856 92 92